Qiang Yu
Oprichter bij Shanghai Ambrosia Pharmaceuticals Co., Ltd.
Profiel
Qiang Yu is the founder of Shanghai Ambrosia Pharmaceuticals Co., Ltd., which was founded in 2002.
He is currently the Chief Executive Officer & Trustee of the company.
Dr. Yu is also the founder of other companies, but no founding dates are provided.
Additionally, Dr. Yu is currently working as a Professor at Shanghai Institute of Organic Chemistry since 2011.
In terms of education, Dr. Yu obtained a doctorate degree from Brandeis University in 1988 and an undergraduate degree from Fudan University in 1982.
Actieve functies van Qiang Yu
Bedrijven | Functie | Begin |
---|---|---|
Shanghai Ambrosia Pharmaceuticals Co., Ltd.
Shanghai Ambrosia Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ambrosia Pharmaceuticals Co., Ltd. develops and manufactures pharmaceutical products. Its products include anti-inflammation drugs to treat leucopenia, hepatitis and viral infections, inflammation, rheumatoid arthritis, asthma and autoimmune diseases. The company was founded by Junying Yuan, Xin-Yuan Fu, Jun Liu and Qiang Yu in 2002 and is headquartered in Pudong, China. | Oprichter | 19-02-2010 |
Shanghai Institute of Organic Chemistry | Corporate Officer/Principal | - |
Opleiding van Qiang Yu
Brandeis University | Doctorate Degree |
Fudan University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Shanghai Ambrosia Pharmaceuticals Co., Ltd.
Shanghai Ambrosia Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ambrosia Pharmaceuticals Co., Ltd. develops and manufactures pharmaceutical products. Its products include anti-inflammation drugs to treat leucopenia, hepatitis and viral infections, inflammation, rheumatoid arthritis, asthma and autoimmune diseases. The company was founded by Junying Yuan, Xin-Yuan Fu, Jun Liu and Qiang Yu in 2002 and is headquartered in Pudong, China. | Health Technology |